OTOP3 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Phosphate Buffered Saline (PBS) with 0.02% Sodium Azide, 50% Glycerol, pH 7.3. Storage at -20°C. Avoid repeated freeze-thaw cycles.
Lead Time
Typically, we can ship the products within 1-3 business days following receipt of your order. Delivery times may vary depending on the purchase method or location. For specific delivery times, please consult your local distributors.
Synonyms
OTOP3 antibody; Proton channel OTOP3 antibody; Otopetrin-3 antibody
Target Names
OTOP3
Uniprot No.

Target Background

Function
OTOP3 Antibody targets a proton-selective channel that facilitates the specific transport of protons into cells. This proton-selective channel activity is likely essential in cell types that utilize changes in intracellular pH for cell signaling or to regulate biochemical or developmental processes.
Database Links

HGNC: 19658

OMIM: 607828

KEGG: hsa:347741

STRING: 9606.ENSP00000328090

UniGene: Hs.454407

Protein Families
Otopetrin family
Subcellular Location
Cell membrane; Multi-pass membrane protein.

Q&A

What is OTOP3 and what are its primary functions in cellular physiology?

OTOP3 belongs to the Otopetrin family of proton-selective ion channels expressed in diverse cell types, functioning primarily in acid detection and pH regulation. While OTOP1 has established roles in vestibular otoconia formation and sour taste reception, the specific physiological functions of OTOP3 remain under investigation . Recent research has revealed that OTOP3 forms proton-selective channels gated by extracellular protons, embedded in the cell membrane as a multi-pass membrane protein .

An emerging functional characteristic of OTOP3 is its responsiveness to transition metals, particularly zinc (Zn²⁺) and copper (Cu²⁺), which potently modulate its activity. Pre-exposure to Zn²⁺ can increase murine OTOP3 (mOTOP3) current magnitude in response to acid stimuli by up to 10-fold, suggesting potential physiological implications given that zinc is an essential micronutrient .

What are the key technical specifications of commercially available OTOP3 antibodies?

Commercial OTOP3 antibodies are primarily rabbit polyclonal antibodies available with various conjugations, including FITC . These antibodies typically target human OTOP3 and some cross-react with rat OTOP3 . Technical specifications include:

  • Concentration: Approximately 1000 μg/ml by Nanodrop measurement and 180 μg/ml by Bradford method using BSA as standard

  • Purification method: Affinity purification

  • Formulation: PBS with preservatives (0.02% sodium azide) and stabilizers (30-50% glycerol)

  • Storage requirements: -20°C for long-term storage, with recommendations to avoid freeze-thaw cycles

  • Molecular weight detection: Expected at 66-70 kDa in Western blot applications

What applications are OTOP3 antibodies validated for in research settings?

OTOP3 antibodies have been validated for multiple research applications with specific protocol recommendations:

  • Western Blot (WB): Working dilutions typically range from 1:500-1:5,000 depending on the manufacturer and specific antibody . Successful detection of OTOP3 has been demonstrated in rat tongue tissue as a positive control .

  • Enzyme-Linked Immunosorbent Assay (ELISA): Recommended dilutions are generally higher than for Western blot, with some manufacturers suggesting 1:50,000 .

  • Immunoprecipitation (IP): Working dilutions around 1:200 are typically recommended .

These applications enable researchers to investigate OTOP3 expression, localization, and potential interactions with other proteins in various experimental systems.

How should researchers optimize Western blot protocols for reliable OTOP3 detection?

Optimizing Western blot detection of OTOP3 requires careful consideration of several methodological aspects:

  • Sample preparation: As OTOP3 is a multi-pass membrane protein , effective extraction requires appropriate membrane protein solubilization protocols. Consider using specialized membrane protein extraction buffers containing gentle detergents like Triton X-100 or CHAPS.

  • Positive controls: Incorporate rat tongue tissue as a validated positive control . This tissue has shown consistent OTOP3 expression and enables verification of proper antibody function.

  • Loading controls: Select membrane protein-appropriate loading controls rather than cytosolic proteins to accurately normalize OTOP3 expression levels.

  • Antibody dilution optimization: Begin with the manufacturer's recommended range (e.g., 1:1000-1:4000 ), then perform systematic dilution series to determine optimal signal-to-noise ratio for your specific sample types.

  • Detection method: For the 66-70 kDa OTOP3 protein , enhanced chemiluminescence (ECL) with appropriate exposure times generally provides sufficient sensitivity. For quantitative analysis, consider fluorescence-based detection systems.

  • Blocking optimization: Since some OTOP3 antibodies contain BSA in their formulation , optimize blocking conditions to minimize background while maximizing specific signal.

What strategies can researchers employ to study OTOP3 channel gating mechanisms?

Investigating OTOP3 channel gating requires specialized electrophysiological and molecular approaches:

  • Patch-clamp recording: This represents the gold standard for functional characterization of OTOP3 channels. Key methodological considerations include:

    • Expression system: HEK293 cells provide a reliable heterologous expression system for OTOP channels

    • Recording configuration: Whole-cell configuration with membrane potentials typically held at -80 mV

    • Solution exchange: Fast-step perfusion systems enable precise temporal control of solution application

    • Data acquisition: Sampling at 5 kHz with 1 kHz filtering provides appropriate resolution for OTOP3 kinetics

  • Site-directed mutagenesis: Targeting specific residues implicated in channel function allows dissection of gating mechanisms. Critical residues for OTOP3 include:

    • H531 and E535 within the transmembrane (tm) 11-12 linker

    • H234 and E238 within the tm 5-6 linker

  • Chimeric channel construction: Swapping domains between OTOP family members has proven highly informative. For example, exchanging the tm 11-12 linker between mOTOP3 and mOTOP2 transferred Zn²⁺ sensitivity between the channels .

  • Pharmacological modulation: Utilizing modulators like Zn²⁺ and Cu²⁺ at varying concentrations and exposure protocols helps elucidate allosteric regulation mechanisms .

How can researchers differentiate between OTOP family members in experimental systems?

Distinguishing between OTOP1, OTOP2, and OTOP3 requires careful experimental design:

  • Antibody selection: Choose antibodies validated for specificity against individual OTOP family members. Review immunogen information to confirm targeting of unique epitopes rather than conserved regions.

  • Functional differentiation: Exploit known functional differences between OTOP family members:

    • OTOP3 shows robust potentiation by Zn²⁺, while OTOP2 is insensitive to Zn²⁺ activation

    • OTOP1 exhibits intermediate Zn²⁺ sensitivity compared to OTOP3

  • Molecular analysis: Use RT-PCR with primers specific to unique regions of each OTOP family member to verify expression patterns before protein analysis.

  • Structural considerations: Target antibodies to regions with known sequence divergence, such as the tm 11-12 linker, which differs significantly between OTOP family members and contributes to their functional differences .

  • Control experiments: Employ heterologous expression systems with defined OTOP isoform expression to establish clear positive controls for antibody specificity testing.

How does zinc modulate OTOP3 channel activity at the molecular level?

Zinc modulation of OTOP3 involves complex molecular mechanisms with both potentiating and inhibitory effects:

  • Dual modulatory effects:

    • Potentiation: Pre-exposure to Zn²⁺ at neutral pH (7.4) increases subsequent acid-evoked (pH 5.5) mOTOP3 currents by up to 10-fold

    • Inhibition: When applied simultaneously with acid stimuli, Zn²⁺ inhibits mOTOP3 currents with an IC₅₀ of 0.31 mM

  • Molecular determinants: The Zn²⁺ binding site involves multiple coordinating residues:

    • H531 in the tm 11-12 linker is critical; mutation to alanine or arginine eliminates Zn²⁺ potentiation

    • E535 in the tm 11-12 linker contributes partially; mutation to alanine reduces but doesn't eliminate potentiation

    • H234 and E238 in the tm 5-6 linker also participate; alanine mutations significantly reduce potentiation

  • Mechanistic model: Kinetic modeling suggests Zn²⁺ stabilizes the open state of the channel, competing with H⁺ for activation . The distinct dose dependencies of inhibition and potentiation indicate separate binding sites for these effects.

  • Structural insights: AlphaFold predictions suggest a Zn²⁺ binding site formed by the coordinated arrangement of H531, E535, H234, and E238 , providing a structural basis for this regulation.

  • Specificity within the OTOP family: This Zn²⁺ potentiation is specific to OTOP3 (and partially to OTOP1) but absent in OTOP2, highlighting evolutionary specialization of channel regulation within this family .

What structural features of OTOP3 are critical for antibody targeting and experimental design?

Understanding OTOP3's structural features is essential for effective antibody selection and experimental design:

  • Transmembrane topology: As a multi-pass membrane protein , OTOP3 presents limited extracellular and intracellular domains for antibody targeting. Consider this topology when designing experiments involving intact cells versus lysates.

  • Critical functional domains: Key regulatory regions include:

    • The tm 11-12 linker (containing H531 and E535): Essential for Zn²⁺ modulation

    • The tm 5-6 linker (containing H234 and E238): Contributes to Zn²⁺ binding

    • These domains represent both important epitope targets and regions for functional studies

  • Sequence conservation: The tm 11-12 linker consists of sixteen amino acids, with five conserved between the three murine OTOP channels . This mix of conserved and variable regions affects antibody specificity across OTOP family members.

  • Species considerations: While the core channel architecture is conserved, species-specific variations exist. Commercial antibodies have been validated for human and rat OTOP3 , but cross-reactivity with other species requires verification.

  • Post-translational modifications: Consider potential modifications that might affect antibody recognition or channel function when designing experiments or interpreting results.

What are the most effective approaches for validating OTOP3 antibody specificity?

Rigorous validation of OTOP3 antibody specificity requires a multi-faceted approach:

  • Molecular weight verification: Confirm detection at the expected 66-70 kDa range for OTOP3 . Secondary bands may indicate non-specific binding or degradation products.

  • Multiple antibody comparison: Utilize antibodies targeting different OTOP3 epitopes and compare detection patterns across applications.

  • Positive control tissues: Incorporate validated positive controls such as rat tongue tissue to ensure consistent detection across experiments.

  • Knockdown/knockout validation:

    • siRNA knockdown: Verify reduced signal intensity proportional to knockdown efficiency

    • CRISPR/Cas9 knockout: Should completely eliminate specific antibody signal

    • Overexpression: Ectopic expression in cell lines with minimal endogenous OTOP3 should produce signal at the correct molecular weight

  • Peptide competition: Pre-incubation of antibody with immunizing peptide should abolish specific signal if the antibody is truly specific.

  • Cross-reactivity assessment: Test against heterologously expressed OTOP1 and OTOP2 to confirm absence of cross-reactivity with other family members.

  • Orthogonal detection methods: Complement antibody detection with mass spectrometry or RNA expression analysis to confirm OTOP3 presence in your experimental system.

What factors might contribute to inconsistent results in OTOP3 detection and functional studies?

Several experimental factors can lead to variability in OTOP3 research:

  • Membrane protein extraction challenges:

    • Inefficient solubilization may result in variable yields

    • Detergent choice significantly impacts membrane protein integrity

    • Temperature sensitivity during extraction can affect protein stability

  • Expression level heterogeneity:

    • Natural variation in OTOP3 expression across tissues and cell types

    • Potential regulation by physiological conditions such as pH or zinc levels

    • Experimental treatments may inadvertently alter expression

  • Technical considerations:

    • Antibody lot-to-lot variability affects detection consistency

    • Storage conditions of both samples and antibodies impact stability

    • Protocol variations between laboratories hinder cross-study comparison

  • Functional complexity:

    • Dual effects of modulators like Zn²⁺ (both activating and inhibitory)

    • Time-dependent aspects of channel modulation

    • Context-dependent effects based on pH, ion concentrations, and membrane potential

  • Experimental system differences:

    • Native tissue versus heterologous expression systems

    • Species variations in OTOP3 sequence and regulation

    • Presence of endogenous modulators or interacting proteins

How can researchers address common technical challenges when studying OTOP3 channels?

Researchers can implement several strategies to overcome technical challenges:

  • For membrane protein extraction issues:

    • Optimize detergent type and concentration specifically for OTOP3

    • Consider using specialized membrane protein extraction kits

    • Maintain consistent temperature conditions throughout extraction

    • Verify extraction efficiency with membrane protein markers

  • For antibody-related challenges:

    • Perform systematic dilution series for each new antibody lot

    • Include standard positive controls (e.g., rat tongue tissue ) in each experiment

    • Store antibodies in small aliquots to minimize freeze-thaw cycles

    • Consider fixation and permeabilization optimization for immunofluorescence applications

  • For functional studies:

    • Standardize cell culture conditions for heterologous expression

    • Control for passage number effects in cell lines

    • Implement consistent solution exchange protocols in patch-clamp studies

    • Account for desensitization by using consistent time intervals between stimuli

  • For data interpretation:

    • Distinguish between potentiating and inhibitory effects of modulators

    • Consider kinetic aspects of channel modulation

    • Account for potential interactions between different modulators

    • Implement appropriate statistical analyses for variability assessment

How can conflicting data in OTOP3 research be reconciled through methodological improvements?

Addressing conflicting findings requires methodological refinements:

  • Standardize experimental conditions:

    • Establish consistent protocols for channel expression, recording solutions, and stimulation parameters

    • Document detailed methodological parameters to enable accurate replication

    • Consider developing standard positive and negative controls for the field

  • Implement more rigorous controls:

    • Include parallel experiments with OTOP1 and OTOP2 to highlight family member-specific effects

    • Use channel mutants with altered function (e.g., H531A for OTOP3 ) as internal controls

    • Design concentration-response curves rather than single-point measurements

  • Account for contextual factors:

    • Systematically investigate the influence of pH, divalent cations, and temperature

    • Consider membrane composition effects on channel function

    • Assess potential accessory proteins that might modulate channel activity

  • Cross-validate with complementary techniques:

    • Combine electrophysiology with fluorescence-based assays

    • Correlate protein expression levels with functional responses

    • Implement computational modeling to test mechanistic hypotheses

  • Collaborative approaches:

    • Establish multi-laboratory validation studies

    • Develop shared resources such as verified constructs and antibodies

    • Create standardized reporting formats for OTOP channel research

What physiological roles for OTOP3 are suggested by recent molecular findings?

Recent molecular insights suggest several potential physiological roles for OTOP3:

  • Zinc-modulated pH sensing: The potent activation of OTOP3 by zinc suggests a potential role in tissues where zinc and pH fluctuations coincide. This could include:

    • Gastrointestinal tract, where both zinc availability and pH variations are physiologically relevant

    • Synaptic environments, where zinc is co-released with neurotransmitters at certain synapses

    • Immune cell microenvironments, which experience pH changes during inflammation

  • Homeostatic regulation: The dual modulation by protons and zinc suggests OTOP3 might serve as an integrative sensor in homeostatic systems regulating both pH and zinc levels.

  • Specialized sensory functions: Given OTOP1's established role in sour taste and vestibular function, OTOP3 might serve analogous specialized sensory roles in other tissues.

  • Pathophysiological responses: OTOP3 could participate in cellular responses to conditions involving acidosis coupled with altered zinc homeostasis, such as ischemia or inflammation.

  • Developmental processes: The timing of OTOP3 expression during development could provide clues to potential roles in tissue differentiation or maturation.

What are promising future research directions for OTOP3 antibodies in basic and translational science?

Several research directions show particular promise:

  • Comprehensive expression mapping:

    • Systematic immunohistochemical analysis across tissues and developmental stages

    • Single-cell resolution studies to identify specific OTOP3-expressing cell populations

    • Correlation of expression patterns with functional properties of different tissues

  • Structure-function investigations:

    • Epitope mapping to develop antibodies targeting specific functional domains

    • Antibodies as tools to probe conformational changes during channel activation

    • Development of conformation-specific antibodies to detect active versus inactive channels

  • Regulatory mechanisms:

    • Investigation of post-translational modifications using modification-specific antibodies

    • Analysis of protein-protein interactions through co-immunoprecipitation

    • Tracking of subcellular trafficking and membrane insertion dynamics

  • Pathophysiological relevance:

    • Expression analysis in disease models involving altered pH regulation

    • Investigation of OTOP3 in conditions with disrupted zinc homeostasis

    • Potential involvement in inflammatory or ischemic conditions

  • Therapeutic applications:

    • Development of function-modulating antibodies as research tools

    • Screening for small molecule modulators using antibody-based assays

    • Investigation of channel-targeting approaches for conditions involving dysregulated pH sensing

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.